These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35641210)

  • 1. Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
    Nardi V; McAfee SL; Dal Cin P; Tsai HK; Amrein PC; Hobbs GS; Brunner AM; Narayan R; Foster J; Fathi AT; Hock H
    Oncologist; 2022 Mar; 27(2):82-86. PubMed ID: 35641210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic
    Stukaite-Ruibiene E; Norvilas R; Dirse V; Stankeviciene S; Vaitkeviciene GE
    Pathol Oncol Res; 2022; 28():1610570. PubMed ID: 36172171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.
    Simioni C; Ultimo S; Martelli AM; Zauli G; Milani D; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2016 Nov; 7(48):79842-79853. PubMed ID: 27821800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of a cryptic
    Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
    Tan KW; Zhu YY; Qiu QC; Wang M; Shen HJ; Huang SM; Cao HY; Wan CL; Li YY; Dai HP; Xue SL
    Ann Hematol; 2023 Sep; 102(9):2397-2402. PubMed ID: 37103615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
    De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
    Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.
    De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O
    Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.
    Quintás-Cardama A; Tong W; Manshouri T; Vega F; Lennon PA; Cools J; Gilliland DG; Lee F; Cortes J; Kantarjian H; Garcia-Manero G
    Leukemia; 2008 Jun; 22(6):1117-24. PubMed ID: 18401417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
    Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
    Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia.
    Tsujimoto SI; Nakano Y; Osumi T; Okada K; Ouchi-Uchiyama M; Kataoka K; Fujii Y; Ohki K; Seki M; Tamagawa N; Takita J; Ogawa S; Kiyokawa N; Hara J; Kato M
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):e397-e399. PubMed ID: 29219890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and
    Chen Y; Zhang L; Huang J; Hong X; Zhao J; Wang Z; Zhang K
    Exp Ther Med; 2017 Nov; 14(5):3979-3984. PubMed ID: 29067094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
    Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
    Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABL1 fusions in T-cell acute lymphoblastic leukemia.
    De Keersmaecker K
    Verh K Acad Geneeskd Belg; 2008; 70(4):245-55. PubMed ID: 19166098
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Choi YJ; Min YK; Lee ST; Choi JR; Shin S
    Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute.
    Kidoguchi K; Ureshino H; Kizuka-Sano H; Yamaguchi K; Katsuya H; Kubota Y; Ando T; Miura M; Takahashi N; Kimura S
    Int J Hematol; 2021 Aug; 114(2):199-204. PubMed ID: 33907977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance.
    Ballerini P; Busson M; Fasola S; van den Akker J; Lapillonne H; Romana SP; Marynen P; Bernard OA; Landman-Parker J; Berger R
    Leukemia; 2005 Mar; 19(3):468-70. PubMed ID: 15674415
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
    Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
    Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.
    Iacobucci I; Roberts KG
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34062932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.
    Nardi V; Ku N; Frigault MJ; Dubuc AM; Tsai HK; Amrein PC; Hobbs GS; Brunner AM; Narayan R; Burke ME; Foster J; Dal Cin P; Maus MV; Fathi AT; Hock H
    Blood Adv; 2020 Jan; 4(1):106-111. PubMed ID: 31905241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.